NDC 61748-017

IsonaRif

Rifampin And Isoniazid

IsonaRif is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Versapharm Incorporated. The primary component is Rifampin; Isoniazid.

Product ID61748-017_1d3f27ec-1616-40fd-bc4f-91bb1744ceb0
NDC61748-017
Product TypeHuman Prescription Drug
Proprietary NameIsonaRif
Generic NameRifampin And Isoniazid
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2005-09-01
Marketing CategoryANDA / ANDA
Application NumberANDA065221
Labeler NameVersaPharm Incorporated
Substance NameRIFAMPIN; ISONIAZID
Active Ingredient Strength300 mg/1; mg/1
Pharm ClassesRifamycin Antibacterial [EPC],Rifamycins [CS],Antimycobacterial [EPC]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 61748-017-60

60 CAPSULE in 1 BOTTLE (61748-017-60)
Marketing Start Date2005-09-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61748-017-60 [61748001760]

IsonaRif CAPSULE
Marketing CategoryANDA
Application NumberANDA065221
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-09-01
Inactivation Date2020-01-31

NDC 61748-017-36 [61748001736]

IsonaRif CAPSULE
Marketing CategoryANDA
Application NumberANDA081118
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1997-07-21
Marketing End Date2001-01-01

Drug Details

Active Ingredients

IngredientStrength
RIFAMPIN300 mg/1

OpenFDA Data

SPL SET ID:1d3f27ec-1616-40fd-bc4f-91bb1744ceb0
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198203
  • 631357
  • UPC Code
  • 0361748017607
  • Pharmacological Class

    • Rifamycin Antibacterial [EPC]
    • Rifamycins [CS]
    • Antimycobacterial [EPC]

    NDC Crossover Matching brand name "IsonaRif" or generic name "Rifampin And Isoniazid"

    NDCBrand NameGeneric Name
    61748-017IsonaRifRifampin and Isoniazid
    0068-0509Rifamaterifampin and isoniazid

    Trademark Results [IsonaRif]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ISONARIF
    ISONARIF
    78755383 3235289 Dead/Cancelled
    Covenant Pharma Inc.
    2005-11-16

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.